Yuanjian Xu is an author at Tongji University specializing in crispr, genome engineering, and medicine.
Top concepts
CrisprMedicineHepatitisHepatologyImmunologyCell BiologyGene EditingGenome EditingViral HepatitisGenome Engineering
Publications per year
2016–2016
1
1
CRISPR/Cas9 produces anti-hepatitis B virus effect in hepatoma cells and transgenic mouse
Wei Zhu, Kun Xie, Yuanjian Xu et al. · Virus Research · 2016 · 64 citations
Rows per page
1–1 of 1